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AGE, MENOPAUSAL STATUS AND THE BLADDER MICROBIOME 
Natasha Curtiss, Aswini Balachandran, Louise Krska, Claire Peppiatt-Wildman, Scott Wildman, 
Jonathan Duckett 
Abstract 
Objectives: The bladder is not sterile but contains a healthy community of microbes termed 
the microbiome. Alterations in the bladder microbiome have been demonstrated in disease 
states such as the overactive bladder. The microbiome in other anatomical niches is known 
to alter with age eg the vagina. The objective of this study was to identify if the bladder 
microbiome  in healthy women  varies with age and  menopausal status. 
Study design: Urine from 79 healthy women attending secondary care gynaecological clinics 
with no urinary symptoms provided clean catch mid-stream urine specimens. Urine was 
centrifuged and the resultant pellet was re-suspended and inoculated onto chocolate agar 
plates and cultured under either aerobic or anaerobic conditions. Morphologically different 
colonies were purity plated and 16s rRNA gene sequencing was performed. A microbe 
genomic basic local alignment search tool (BLAST) was used to identify the genus of the 
bacteria.  
Results: There was no significant correlation between the age of a woman and the number 
of different genera identified (r=-0.034, p=0.79). There were few significant differences in 
the frequency with which the majority of organisms were found in pre and post-menopausal 
women. The exceptions however were lactobacillus, which was more common in pre-
menopausal women (31 vs 3 p=0.002) and Mobiluncus, which was more common in post-
menopausal women (0 vs 3 p=0.02). 
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Conclusions: There was no significant correlation between patient age and diversity of the 
bladder microbiome but large numbers of different organisms were identified. Significant 
differences were however observed for Lactobacillus which is more common in pre-























Several different centres around the world have established the presence of a bladder 
microbiome [1,2].  This complex interaction between microbes and host has been shown to 
be different in healthy individuals compared to those with a disease process such as OAB 
[3,4]. The microbiome is known to alter in other body systems with external factors. The gut 
microbiome changes with external factors and also with age [5]. The vaginal microbiome 
also alters with age and estrogenisation [6]. The vagina is anatomically closely related to the 
bladder and any change in the vaginal microbiome might be expected to be reflected in 
changes in the bladder microbiome. It stands to reason that the bladder microbiome 
likewise will alter with age and menopausal status.  The only previous study on the bladder 
microbiome and age include only 6 men and 10 women. This small study found the 
microbiome appears to alter with age [2] around a core microbiome but was too small to 
draw statistical conclusions on the changes of the bladder microbiome with age. This study 










Materials and Methods 
The microbiome of 79 healthy women attending a secondary care general gynaecology clinic 
and members of staff were included. This was a consecutive cohort study with patients 
compared by age.  Ethical approval was registered (ClinicalTrials.gov: NCT 02536872). This 
study used previously collected control data from earlier work on the bladder microbiome in 
overactive bladder (35 cases) [7] with additional cases (44) to increase power.  Inclusion 
criteria included patients/staff who did not score on the ICIQ short form questionnaire 
(International consultation on incontinence modular questionnaire – Urinary incontinence 
short form). Women using hormonal medication such as the progesterone only 
contraceptives (9 patients) or hormone replacement (2) were excluded. Patients taking 
medication to down regulate hormone production were also excluded (2). There were no 
combined contraceptive pill users in the cohort.  Volunteers provided a clean catch voided 
urine sample into a sterile container. The samples were immediately tested for nitrites 
(Siemens Multistix@8SG), and any patients testing positive were excluded.  
A pellet was formed from 5 ml of each urine sample by centrifuging it at 800 rpm for 5 mins.  
This pellet was re-suspended in 50 μl of the supernatant and 5 μl inoculated onto two 
chocolate agar plates (E and O laboratories) by streaking.  The plates were incubated at 
37oC, one in 5% CO2 (48 hours) and the other in anaerobic conditions (7 days). Following 
incubation, morphologically different colonies were taken and purity plated on chocolate 
agar plates for 48 hours using the same conditions for growth. Aseptic techniques were 
employed throughout. Sequencing of the 16s rRNA gene was performed as follows. An 
Eppendorf Mastercycler set to 94OC for 5 minutes was used to lysis bacteria from 5 μl 
inoculations of isolates suspended in 100 μl sterile nuclease free water (Thermo Scientific). 
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Lysed bacterial samples underwent polymerase chain reaction (PCR) to amplify a variable 
region of the bacterial 16rRNA gene.  The primers used were; (DG74Fwd - 5’-AGG AGC TGA 
TCC AAC CGC A-3’ - Eurofins) and (RDR080Rev - 5’-AAC TGG AGG AAG GTG GGG AC-3’-
Eurofins).   A 1% agarose gel loaded with the PCR amplicons was checked for reaction 
success against a negative control.  
A PCR Purification Kit (Qiagen) was used to purifiy the DNA.  The concentration of each 
product was measured using a Nanodrop 2000 (Thermo Scientific). Sequencing was 
performed by Eurofins Genomics, Ebersburg, Germany. A microbe genomic BLAST (Basic 
Local Alignment Search Tool, PubMed) was used to identify the genus of bacteria from the 
sequences. Some sequences could not be identified and were excluded from further 
analysis. 
16s rRNA gene sequence information was used to compare the microbiomes across all 
patients. Patients were catagorised as pre-menopausal and post-menopausal and 
differences in their microbiomes were analysed by Fisher’s Exact test. Microbiomes were 
also analysed by age using Pearson Correlation coefficient. A formal power calculation was 
not performed as this was a proof of concept study and sought to evaluate associations 
reported in previous studies. Sample size calculations are difficult when means and standard 
deviations are uncertain. A minimum sample size of more than 25 in each arm has been 






The urine from 79 women was analysed. In total 60 different genera were identified in the 
urine from the women analysed. 
The diversity of the bladder microbiome was investigated by plotting age against 
number of genera identified (fig 1). There was not a significant correlation between the age 
of a woman and the number of different genera identified (statistical analysis using Pearson 
Correlation Coefficient r= -0.034 p=0.79). There is a trend towards decreased numbers of 
different genera in urine from post-menopausal women but this did not reach statistical 
significance. 
There were few significant differences in the frequency at which majority of 
organisms were found in the microbiome of pre-menopaual and post-menopausal women. 
The exceptions were lactobacillus which was significantly more common in pre-menopausal 
women than post-menopausal women (31 pre-menopausal vs 3 post-menopausal p= 0.002) 
and Mobiluncus which was more common in postmenopausal women (3 post-menopausal 
vs 0 pre-menopausal p=0.02). The distribution of the genera identified in pre and post-
menopausal women are depicted in figure 2. We identified a decrease in the growth of 









In common with smaller studies we found no correlation between age and diversity as 
measured by number of genera identified [2]. There was a significantly greater incidence of 
Lactobacillus in the bladder microbiome of pre-menopausal women than post-menopausal 
women (p= 0.003) and Mobiluncus was significantly more common in postmenopausal 
women (p=0.02). There were differences in the genera identified in the bladder of pre-
menopausal women and post-menopausal women with some genera common to both.  
This study adds valuable information to the developing understanding of the female 
urinary microbiome. Our results along with other studies are developing a picture of the 
core female urinary microbiome (FUM) [9]. By establishing the norm, we may increasingly 
be able to detect differences in bacterial colonisation of the bladder in health and disease 
with a view to manipulating the microbiome therapeutically to restore homeostasis. We 
identified 60 different genera across all patients. Some were found exclusively in younger 
and older women but a core of genera were found in all age groups. The bacteria most 
commonly found in urine by many research groups; Streptococcus, staphylococcus, 
Corynebacterium and lactobacillus [1,3,10] are all within this core (fig 2). 
Finding older women with no urinary symptoms was difficult and we were only able 
to recruit 19 suitable women in our study. Difficulties in obtaining age matched controls is 
not a new phenomenon and has been described by previous researchers [11]. It is well 
documented that there is an increase in the prevalence of OAB with age, and women 
attending the general gynaecology clinic after the menopause with no symptoms of 
prolapse or urinary symptoms is a rare occurrence. In light of this, general conclusions are 
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more difficult to make and some subtle changes in the bladder microbiome may remain 
undetected. 
There is a trend towards decreased numbers of different genera in-post menopausal 
specimens that did not reach statistical significance in this study, perhaps due to sample 
number. This concept of decreased numbers of genera is not unique to the urinary tract 
system, studies looking at the effect of ageing on the gut microbiome shows an overall loss 
in diversity alongside changes in the make up of the microbiome with increasing numbers of 
facultative anaerobes [12]. Data from another study where next generation sequencing was 
employed to investigate the bladder microbiome albeit in a small number of patinets 
mirrored our results. On average less genera were identified in women over 50 years old 
and a decrease in overall bacterial load was noted in this group compared to women aged 
20-49 [2]. Unfortunately, our method is not quantitative and no comment can be made 
regarding how the overall bacterial load alters with age. Any culture and PCR amplification 
methods cannot by their nature be quantitative as they rely on different growth rates and 
are subject to potential PCR primer biases. Patients using hormonal medication for example 
progesterone only contraceptive pill or those using a progesterone coil were excluded as the 
effect of progesterones on the microbiome is uncertain. Progesterones may induce changes 
in the urogenital tract consistent with a pregnancy state which may alter the urinary 
microbiome.  Those on HRT (2) were excluded from the study because it would be expected 
that the HRT might recreate the microbiome seen in premenopausal women. The exact 
effect of different exogenous hormones is uncertain but it seemed sensible to exclude those 
patients taking hormones which might alter the bladder microbiome. 
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Lactobacillus has been  established as a component of the bladder microbiome of 
women [7] although its variation with age has not previously been noted. Lactobacillus is 
also a key component of the normal vaginal microbiome. This study used clean catch MSU 
samples but there is debate as to whether MSUs or CSUs are the best way to sample the 
bladder microbiome [13]. Asymptomatic patients with no urinary symptoms, in common 
with those in other studies, found CSUs unacceptable [11]. There could be concerns that by 
using clean catch midstream urine samples there might be vaginal contamination and that 
these results may be confounded by the decline in vaginal lactobacillus with age. However, 
MSUs have been used extensively in the past and may continue to be used until the benefit 
of one technique over the other is established [2]. CSUs may be more easily justified in 
symptomatic patients.  
Potential weaknesses of the study include the size of the study and the use of MSU 
samples. The study might fail to identify small differences in the bladder microbiome. 
Second generation sequencing in a larger sample might provide some further support to the 
findings of the study but there are also limitations with this methodology and analysis of the 
results produced by this method is complex. The effect of exogenous hormones on the 
bladder microbiome is uncertain and certain presumptions have been made in assessing the 
effect that might be supposed. Further study in this area is warranted although the 
methodology to achieve this is difficult. In general patients taking exogenous hormones 
were excluded to reduce the risk of this affecting the results.   
This study characterises the bladder microbiome in health in different age groups. As 
expected the microbiome does alter with age. This study shows the crucial importance that 
age has on the bladder microbiome in healthy patients without bladder symptoms. Any 
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further research in this area should take account of the natural variation that occurs with 
age before any variations in the bladder microbiome can be attributed to a disease process. 
This study will allow us to compare the bladder microbiome in health to that seen in 
different disease states such as OAB. Many organisms live in the bladder and exist without 
giving symptoms.  Further work is important to identify the relevance of different organisms 






















1.! Hilt EE, McKinley K, Pearce MM, Rosenfeld AB et al. Urine is not sterile: use of 
enhanced urine culture techniques to detect resident bacterial flora in the adult 
female bladder. J Clin Microbiol 2014;52:871-6.  
2.! Lewis, DA, Brown R, Williams J et al. The human urinary microbiome: bacterial DNA 
in voided urine of asymptomatic adults. Front Cell Infect Microbiol 2013;3:41.  
3.! Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ et al. The female urinary microbiome: a 
comparison of women with and without urgency urinary incontinence. MBio 2014 
doi: 10.1128/mBio.01283-14. 
4.! Brubaker L, Nager CW, Richter HE et al. Urinary bacteria in adult women with 
urgency urinary incontinence. Int Urogynecol J 2014;25:1179-84. 
5.!  Kumar M, Babaei P, Ji B, Nielsen J. Human gut microbiota and healthy aging: Recent 
developments and future prospective. Nutrition and Healthy Aging. 2016;4(1):3-16. 
6.! Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal 
microbiota, menopause status and signs of vulvovaginal atrophy. Menopause (New 
York, NY). 2014;21(5):450-458.  
7.! Curtiss N, Balachandran A, Krska L, Peppiatt-Wildman C, Wildman S, Duckett J.A case 
controlled study examining the bladder microbiome in women with Overactive 
Bladder (OAB) and healthy controls. Eur J Obstet Gynecol Reprod Biol 2017;214:31-
35.  
8.! Machin D, Campbell M, Fayers P, Pinol A. 1997. Sample size tables for clinical studies. 
Blackwell. Oxford. 
 13 
9.! Brubaker L, Wolfe AJ. The female urinary microbiota, urinary health and common urinary 
disorders. Ann Transl Med 2017;5:34.  
10.!Karstens L, Asquith M, Davin S et al. Does the Urinary Microbiome Play a Role in Urgency 
Urinary Incontinence and its severity? Front Cell Infect Microbiol.2016; 6:78.  
11.!Khasriya R, Sathiananthamoorthy S, Ismail S et al. Spectrum of bacterial colonization 
associated with urothelial cells from patients with chronic lower urinary tract 
symptoms. J Clin Microbiol 2013;51:2054-62. 
12.!Biagi E, Candela M, Fairweather-Tait S et al. Ageing of the human metaorganism: the 
microbial counterpart. Age. 2012;34(1):247-267.  
13.!Moore KH, Malykhina AP What is the role of covert infection in detrusor overactivity, 







































Figure  2 






Table 1: Results depicted by age range 
Age Number Lactobacillus 
(%) 




10-19 1 1       (100%) 6.0 0   (0%) 
20-29 23 16    (69.9%) 5.7           (1-12) 0   (0%) 
30-39 17 11    (64.7%) 5.4           (1-10) 0   (0%) 
40-49 16 10    (62.5%) 5.4           (0-11) 0   (0%) 
50-59 14 5      (35.7%) 4.8           (1-8)  11 (78.6%) 
60-69 5 1      (20%) 3.8           (1-8) 5   (100) 
70-79 2 0      (0%) 7.5           (1-2) 2   (100) 
80-89 1 0      (0%) 9.0 1   (100) 
 
 
